RIORAFT
Sodium Alginate 250 mg, Sodium Bicarbonate 106.5 mg, Calcium Carbonate 187.5 mg Chewable Tab
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | RIORAFT |
| Active Formulation (Salt) | Sodium Alginate 250 mg, Sodium Bicarbonate 106.5 mg, Calcium Carbonate 187.5 mg Chewable Tab |
| Dosage Form | TABLETS |
| Packaging Presentation | 10 x 9 Blister |
| Therapeutic Category | TABLETS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is RIORAFT?
Therapeutic monograph and clinical profile
RIORAFT (Sodium Alginate 250 mg, Sodium Bicarbonate 106.5 mg, Calcium Carbonate 187.5 mg Chewable Tab) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 10 x 9 Blister, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Heartburn / Acid Reflux & GERD.
Key Formulation Highlights
Why healthcare professionals recommend RIORAFT
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Heartburn / Acid Reflux & GERD
Pharmacological Mechanism of Action
How RIORAFT acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for RIORAFT
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for RIORAFT across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding RIORAFT
What is RIORAFT used for?
What is the active composition of RIORAFT?
How can I get monopoly PCD franchise for RIORAFT in my district?
What is the packaging and MRP of RIORAFT?
Related Formulations in TABLETS
Explore complementary WHO-GMP certified healthcare formulations
